ITMCTR2200005628尚未招募未知
Runzaoyin in the treatment of primary Sjogren's syndrome Clinical observation of spleen deficiency and fluid deficiency syndrome
Xiyuan Hospital, Chinese Academy of traditional Chinese medical science0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- All
入选标准
- •? Meet the classification criteria of ACR and EULAR primary Sjogren's syndrome in 2016; ? Spleen deficiency and fluid deficiency syndrome conforming to the standard of TCM syndrome differentiation; ? Age 18-70 years; ? Informed and signed informed consent.
排除标准
- •? It belongs to secondary Sjogren's syndrome complicated with other connective tissue diseases (such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, etc.); ? Women with family planning during pregnancy, lactation or observation; ? Allergic constitution or allergic to the drug components of the preparation; ? Patients with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system; ? Suspected history of alcohol and drug abuse, or other situations that reduce the possibility of enrollment or complicate enrollment according to the judgment of the researcher, such as frequent changes in the working environment, which is easy to cause loss of follow-up; ? Subjects who have participated or are participating in clinical trials of other drugs within 4 weeks.
研究者
相似试验
进行中(未招募)
Unknown
Stratified medicine in primary Sjogren’s syndromeISRCTN16054712ewcastle upon Tyne Hospitals NHS Foundation Trust600
进行中(未招募)
不适用
eflunomide and Hydroxychloroquine combination therapy for primary Sjogren's SyndromeSjogren's SyndromeEUCTR2014-003140-12-NLMC Utrecht
已完成
3 期
Optimizing DMARD therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combination therapy for patients with primary Sjogren's SyndromeSjogren's disease10003816Keratoconjunctivitis siccaNL-OMON45101niversitair Medisch Centrum Utrecht30
已完成
不适用
Primary Sjögren SyndromePrimary Sjögren's SyndromeNCT01989819University Hospital, Limoges44
尚未招募
2 期
Anti-CD20 for the retreatment of primary Sjögren*s syndrome in patients who were included in the placebo-controlled double blinded rituximab study10003816Sjogren's syndromeNL-OMON32498niversitair Medisch Centrum Groningen30
